FDA clears In-Line's access blood flow monitor:
This article was originally published in Clinica
In-Line Diagnostics has received US FDA 510(k) clearance to market its device for estimating access blood flow rate. The Transcutaneous Access Flow consists of a sensor that uses photo-optical technology to acquire a reading in a matter of minutes, compared to 15-20 minutes with current techniques, claims the Salt Lake City, Utah-based company. The device is for use with In-Line's Crit-Line blood monitoring system.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.